- Home
- AUTL vs NPCT Comparison
AUTL vs NPCT Comparison
Compare AUTL & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.55
Company Overview
Basic Information| Metric | AUTL | NPCT |
|---|---|---|
| Founded | 2014 | 2020 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.6M | 306.8M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUTL | NPCT |
|---|---|---|
| Price | $1.55 | $10.49 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | ★ 3.9M | 107.1K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.82% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $51,128,000.00 | N/A |
| Revenue This Year | $658.11 | N/A |
| Revenue Next Year | $91.34 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 406.67 | N/A |
| 52 Week Low | $1.11 | $8.58 |
| 52 Week High | $3.11 | $10.63 |
Technical Indicators
Market Signals| Indicator | AUTL | NPCT |
|---|---|---|
| Relative Strength Index (RSI) | 58.56 | 43.73 |
| Support Level | $1.31 | $10.47 |
| Resistance Level | $1.61 | $10.59 |
| Average True Range (ATR) | 0.09 | 0.12 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 85.37 | 53.66 |
Price Performance
Historical Comparison AUTL
NPCT
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.